A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Dana-Farber Cancer Institute
Washington University School of Medicine
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
University of Rochester
Intensity Therapeutics, Inc.
Sarcoma Oncology Research Center, LLC
Xencor, Inc.
Tracon Pharmaceuticals Inc.
Stanford University
National Cancer Institute (NCI)
Centre Leon Berard
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
Assaf-Harofeh Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)